Combination Therapy to Treat Fungal Biofilm-Based Infections

Area of Science:

• Mycology
• Infectious Diseases
• Pharmacology

Background:

• Fungal biofilm infections are a growing global health concern.
• These infections, often caused by Candida, Aspergillus, or Cryptococcus species, exhibit high resistance to standard antifungal drugs.
• Limited treatment options, such as echinocandins and liposomal amphotericin B, are available.

Purpose of the Study:

• To review combination therapy as a novel strategy against fungal biofilm infections.
• To discuss in vitro methods for discovering new antibiofilm combinations.
• To provide an overview of the mechanisms of action for promising combination treatments.

Main Methods:

• Literature review focusing on combination antifungal therapies.
• Discussion of in vitro screening techniques for identifying synergistic drug combinations.
• Analysis of the modes of action of effective antibiofilm treatments.

Main Results:

• Combination therapy presents a promising approach to overcome antifungal drug resistance in biofilms.
• In vitro methods are crucial for the discovery and validation of new antibiofilm strategies.
• Understanding treatment mechanisms aids in optimizing existing therapies and developing novel ones.

Conclusions:

• Combination therapy is a key strategy for combating challenging fungal biofilm infections.
• Further research into in vitro methods and mechanisms of action will drive the development of more effective treatments.
• Optimizing combination therapies can enhance treatment efficacy and combat drug resistance.